Our data suggest substantial variation by genotype in the frequency and diversity of natural polymorphisms conferring resistance to NS3/4A protease inhibitors and NS5B polymerase inhibitors in Chinese patients with HIV/HCV co-infection. Here, KRAS is linked to coinfection.